Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on April 28, 2008

Hypertension. 2008
Published online before print April 28, 2008, doi: 10.1161/HYPERTENSIONAHA.108.110163
A more recent version of this article appeared on June 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
51/6/1583    most recent
HYPERTENSIONAHA.108.110163v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dmitrieva, R. I.
Right arrow Articles by Doris, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dmitrieva, R. I.
Right arrow Articles by Doris, P. A.
Related Collections
Right arrow Animal models of human disease
Right arrow Other hypertension
Right arrow Functional genomics
Right arrow Gene expression
Right arrow Hypertension - basic studies

Submitted on January 10, 2008
Revised on January 28, 2008

Hepatocyte Nuclear Factor 1 and Hypertensive Nephropathy

Renata I. Dmitrieva; Cruz A. Hinojos; Eric Boerwinkle; Michael C. Braun; Myriam Fornage; and Peter A. Doris*

From the Institute of Molecular Medicine, University of Texas HSC at Houston.

* To whom correspondence should be addressed. E-mail: peter.a.doris{at}uth.tmc.edu.

Abstract—Hypertension in spontaneously hypertensive rat (SHR) is associated with renal redox stress, and we hypothesized that nephropathy arises in SHR-A3 from altered capacity to mitigate redox stress compared with nephropathy-resistant SHR lines. We measured renal expression of redox genes in distinct lines of the spontaneously hypertensive rat (SHR-A3, SHR-B2, SHR-C) and the normotensive Wistar-Kyoto (WKY) strain. The SHR lines differ in either resisting (SHR-B2, SHR-C) or experiencing hypertensive nephropathy (SHR-A3). Immediately before the emergence of hypertensive renal injury expression of redox genes in SHR-A3 was profoundly altered compared with the injury-resistant SHR lines and WKY. This change appeared to arise in antioxidant genes where 16 of 28 were expressed at 34.3% of the level in the reference strain (WKY). No such change was observed in the injury-resistant SHR lines. We analyzed occurrence of transcription factor matrices in the promoters of the downregulated antioxidant genes. In these genes, the hepatocyte nuclear factor 1 (HNF1) transcription factor matrix was found to be nearly twice as likely to be present and the overall frequency of HNF1 sites was nearly 5 times higher, compared with HNF1 transcription factor matrices in antioxidant genes that were not downregulated. We identified 35 other (nonredox) renal genes regulated by HNF1. These were also significantly downregulated in SHR-A3, but not in SHR-B2 or SHR-C. Finally, expression of genes that comprise HNF1 (Tcf1, Tcf2, and Dcoh) was also downregulated in SHR-A3. The present experiments uncover a major change in transcriptional control by HNF1 that affects redox and other genes and precedes emergence of hypertensive renal injury.


Key words: SHR • hypertension • renal injury • redox stress • transcription